AAAAAA
Results:
1-8
|
Results: 8
Authors:
Robinet, G
Thomas, P
Breton, JL
Lena, H
Gouva, S
Dabouis, G
Bennouna, J
Souquet, PJ
Balmes, P
Thiberville, L
Fournel, P
Quoix, E
Riou, R
Rebattu, P
Perol, M
Paillotin, D
Mornex, F
Citation: G. Robinet et al., Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) Protocol 95-1, ANN ONCOL, 12(1), 2001, pp. 59-67
Authors:
Rebattu, P
Quantin, X
Ardiet, C
Morere, JF
Azarian, MR
Schuller-Lebeau, MP
Pujol, JL
Citation: P. Rebattu et al., Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer, LUNG CANC, 33(2-3), 2001, pp. 277-287
Authors:
Freyer, G
Ligneau, B
Tranchand, B
Ardiet, C
Souquet, PJ
Court-Fortune, I
Riou, R
Rebattu, P
Morignat, E
Boissel, JP
Trillet-Lenoir, V
Girard, P
Citation: G. Freyer et al., The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT), LUNG CANC, 31(2-3), 2001, pp. 247-256
Authors:
Nony, P
Guastalla, JP
Rebattu, P
Landais, P
Lievre, M
Bontemps, L
Itti, P
Beaune, J
Andre-Fouet, X
Janier, M
Citation: P. Nony et al., In vivo measurement of myocardial oxidative metabolism and blood flow doesnot show changes in cancer patients undergoing doxorubicin therapy, CANC CHEMOT, 45(5), 2000, pp. 375-380
Authors:
Freyer, G
Tranchand, B
Ligneau, B
Ardiet, C
Souquet, PJ
Court-Fortune, I
Riou, R
Rebattu, P
Boissel, JP
Trillet-Lenoir, V
Girard, P
Citation: G. Freyer et al., Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study, BR J CL PH, 50(4), 2000, pp. 315-324
Authors:
Voog, E
Merrouche, Y
Trillet-Lenoir, V
Lasset, C
Peaud, PY
Rebattu, P
Negrier, S
Citation: E. Voog et al., Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary, AM J CL ONC, 23(6), 2000, pp. 614-616
Authors:
Lhomme, C
Fumoleau, P
Fargeot, P
Krakowski, Y
Dieras, V
Chauvergne, J
Vennin, P
Rebattu, P
Roche, H
Misset, JL
Lentz, MA
Van Glabbeke, M
Matthieu-Boue, A
Mignard, D
Chevallier, B
Citation: C. Lhomme et al., Results of a European organization for research and treatment of cancer/early clinical studies group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix, J CL ONCOL, 17(10), 1999, pp. 3136-3142
Authors:
Ardiet, CJ
Tranchand, B
Zanetta, S
Guillot, A
Bernard, E
Peguy, M
Rebattu, P
Droz, JP
Citation: Cj. Ardiet et al., A sensitive docetaxel assay in plasma by solid-phase extraction and high performance liquid chromatography-UV detection: Validation and suitability in phase I clinical trial pharmacokinetics, INV NEW DR, 17(4), 1999, pp. 325-333
Risultati:
1-8
|